Induction of tolerance with nondepleting anti-CD4 monoclonal antibodies is associated with down-regulation of TH2 cytokines

Transplantation

Volumn 64, Issue 11, 1997, Pages 1559-1567

  Plain, Karren M ^a   Fava, Lisa ^a   Spinelli, Austin ^a   He, Xiao Yan ^a   Chen, Juchuan ^a   Boyd, Rochelle ^a   Davidson, Cassandra L ^a   Hall, Bruce M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; CYTOLYSIN; GAMMA INTERFERON; GRANZYME A; GRANZYME B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE SYNTHASE; OKT 4; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EFFECTOR CELL; GRAFT SURVIVAL; HEART GRAFT; HELPER CELL; IMMUNOHISTOLOGY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; TRANSPLANTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CYTOKINES; DOWN-REGULATION; GRAFT SURVIVAL; IMMUNOSUPPRESSION; INTERLEUKIN-4; ISOANTIBODIES; MICE; POLYMERASE CHAIN REACTION; RATS; RNA, MESSENGER; TH2 CELLS;

EID: 0031470531     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712150-00009     Document Type: Article

References (58)

1. + suppressor cell and its mechanisms of action. J Exp Med 1990; 171: 141.
2. + T cell subsets in low- and high-responder rat strains. J Immunol 1989; 143: 2828.
3. Nicolls MR, Aversa GG, Pearce NW, et al. Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody. Transplantation 1993; 55: 459.
4. Qin S, Cobbold SP, Pope H, et al. "Infectious" transplantation tolerance. Science 1993; 259: 974.
5. Qin SX, Wise M, Cobbold SP, et al. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 1990; 20: 2737.
6. Hall BM. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell. J Exp Med 1985; 161: 123.
7. Dallman MJ, Mason DW, Webb M. The roles of host and donor cells in the rejection of skin allografts by T cell-deprived rats injected with syngeneic T cells. Eur J Immunol 1982; 12: 511.
8. Hall BM. Cells mediating allograft rejection [published erratum appears in Transplantation 1991 Nov; 52(5): 936]. Transplantation 1991; 51: 1141.
9. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145.
10. Swain SL. CD4 T cell development and cytokine polarization: an overview. J Leukocyte Biol 1995; 57: 795.
11. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13: 151.
12. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems: the differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
13. Kupiec-Weglinski JW, Wasowska B, Papp I, et al. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. J Immunol 1993; 151: 5053.
14. Mottram PL, Han WR, Purcell LJ, McKenzie IFC, Hancock WW. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 1995; 59: 559.
15. Gao Q, Chen N, Field EH. CD4 TH2 cells do not functionally suppress CTL generation in neonatal tolerant mice. Transplantation 1995; 60: 1260.
16. Chen N, Gao Q, Field EH. Prevention of TH1 responses is critical for tolerance. Transplantation 1996; 61: 1076.
17. Binder J, Lehmann M, Graser E, et al. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Transplantation 1996; 61: 804.
18. Krieger NR, Most D, Bromberg JS, et al. Coexistence of TH1-and TH2-type cytokine profiles in anti-CD2 monoclonal antibody-induced tolerance. Transplantation 1996; 62: 1285.
19. Shizuru JA, Alters SE, Fathman CG. Anti-CD4 monoclonal antibodies in therapy: creation of nonclassical tolerance in the adult. Immunol Rev 1992; 129: 105.
20. Shizuru JA, Gregory AK, Chao CT, Fathman CG. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. Science 1987; 237: 278.
21. Herbert J, Roser B. Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants. Transplantation 1988; 46: 128S.
22. + T cells. Transplantation 1992; 54: 483.
23. Darby CR, Bushell A, Morris PJ, Wood KJ. Nondepleting anti-CD4 antibodies in transplantation: evidence that modulation is far less effective than prolonged CD4 blockade. Transplantation 1994; 57: 1419.
24. Chen Z, Cobbold S, Metcalfe S, Waldmann H. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Eur. J Immunol 1992; 22: 805.
25. Cosimi AB, Delmonico FL, Wright JK. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery 1990; 108: 406.
26. Saitovitch D, Bushell A, Mabbs DW, Morris PJ, Woods KJ. Kinetics of the induction of transplantation tolerance with a nondepleting anti-CD4 monoclonal antibody and donor-specific transfusion before transplantation: a critical period of time is required for development of immunological unresponsiveness. Transplantation 1996; 61: 1642.
27. Alters SE, Shizuru JA, Ackerman J, Grossman D, Seydel KB, Fathman CG. Anti-CD4 mediates clonal anergy during transplantation tolerance induction. J Exp Med 1991; 173: 491.
28. Verbanac KM, Carver FM, Haisch CE, Thomas JM. A role for transforming growth factor-beta in the veto mechanisms in transplant tolerance. Transplantation 1994; 57: 893.
29. + T cells in vitro. J Immunol 1996; 156: 2406.
30. Waldor MK, Mitchell D, Kipps TJ, Herzenberg LA, Steinman L. Importance of immunoglobulin isotype in therapy of experimental autoimmune encephalomyelitis with monoclonal anti-CD4 antibody. J Immunol 1987; 139: 3660.
31. DeFoma FJ, MacDonald AB. Analysis of antigens by immunodiffusion and immunoelectrophoresis. In: DeFoma FJ, MacDonald AB, eds. Experimental immunology: a guidebook. New York: Macmillan, 1987: 49.
32. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
33. Leenaerts PL, De RD, Vandeputte M, Waer M. Measurement of alloantibody by flow cytometry. J Immunol Methods 1990; 130: 73.
34. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
35. Penny MJ, Boyd RA, Hall BM. Role of T cells in the mediation of Heymann nephritis. II. Identification of Th1 and cytotoxic cells in glomeruli. Kidney Int 1997; 51: 1059.
36. Siegling A, Lehmann M, Riedel H, et al. A nondepleting anti-rat CD4 monoclonal antibody that suppresses T helper 1-like but not T helper 2-like intragraft lymphokine secretion induces long-term survival of renal allografts. Transplantation 1994; 57: 464.
37. Montgomery RA, Dallman MJ. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J Immunol 1991; 147: 554.
38. Dallman MJ, Porter ACG. Semi-quantitative PCR for the analysis of gene expression. In: McPherson MJ, Quirke P, Taylor GR, eds. PCR: a practical approach. Oxford: IRL Press, 1991: 215.
39. + T cells: induction is inhibited by rat recombinant interleukin 4. J Exp Med 1992; 176: 1551.
40. + T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro. J Exp Med 1995; 182: 5.
41. Colton T. Nonparametric methods: statistics in medicine. Boston: Little, Brown and Company, 1974; 219.
42. McKenzie ANJ, Li X, Largaespada DA, et al. Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J Immunol 1993; 150: 5436.
43. Zunino SJ, Bleakley RC, Martinez J, Hudig D. RNKP-1, a novel killer-associated serine protease gene cloned from RNK-16 cytotoxic lymphocytes. J Immunol 1990; 144: 2001.
44. Derynck R, Jarrett JA, Chen EY, Goeddel DV. The murine transforming growth factor-beta precursor. J Biol Chem 1986; 261: 4377.
45. Cook HT, Ebrahim H, Jansen AS, Foster GR, Largen P, Cattell V. Expression of the gene for inducible nitric oxide synthase in experimental glomerulonephritis in the rat. Clin Exp Immunol 1994; 97: 315.
46. Brostoff SW, Mason DW. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J Immunol 1984; 133: 1938.
47. Hutchings P, O'Reilly L, Parish NM, Waldmann H, Cooke A. The use of a non-depleting anti-CD4 monoclonal antibody to reestablish tolerance to beta cells in NOD mice. Eur J Immunol 1992; 22: 1913.
48. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
49. Josien R, Pannetier C, Douillard P, et al. Graft-infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specific transfusion-induced tolerance in adult rats. Transplantation 1995; 60: 1131.
50. Ishikawa H, Shinkai Y, Yagita H, et al. Molecular cloning of rat cytolysin. J Immunol 1989; 143: 3069.
51. Suranyi MG, Bishop GA, Clayberger C, et al. Lymphocyte adhesion molecules in T cell-mediated lysis of human kidney cells. Kidney Int 1991; 39: 312.
52. Hall BM, Bishop GA, Duggin GG, Horvath JS, Philips J, Tiller DJ. Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet 1984; 2: 247.
53. Morris PJ. Suppression of rejection of organ allografts by alloantibody. Immunol Rev 1980; 49: 93.
54. Benjamin RJ, Waldmann H. Induction of tolerance by monoclonal antibody therapy. Nature 1986; 320: 449.
55. Goronzy J, Weyand CM, Fathman CG. Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4. J Exp Med 1986; 164: 911.
56. Charlton B, Mandel TE. Tolerance to aggregated human IgG but not ovalbumin can be induced by concurrent administration of depleting or non-depleting anti-L3T4 monoclonal antibodies. Immunol Cell Biol 1989; 67: 1.
57. Casscells W, Bazoberry F, Speir E, et al. Transforming growth factor-beta 1 in normal heart and in myocardial infarction. Ann N Y Acad Sci 1990; 593: 148.
58. Hall BM, Jelbart ME, Gurley KE, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine: mediation of specific suppression by T helper/inducer cells. J Exp Med 1985; 162: 1683.